Cancer Immunotherapy Market by Application - (Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others), by Product Type – by Mode of Administration – (Intravenous, Oral, Topical, Intravesical), by End users (Hospitals, Clinics) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
We Think Through Different Layers, We Work Across Different Verticals
PR-Inside.com: 2017-09-13 14:12:43
The Global Cancer Immunotherapy Market was worth $ 62 Billion in 2016 and estimated to reach $ 111.23 Billion by the end of 2021 with a growing potential of 12.40 %.
View report: marketdataforecast.com/market-reports/global-cancer-immunotherap ..
Immunotherapy is a treatment option which uses certain parts of immune system to fight against various diseases such as cancer. Immunotherapy which is also known as biologic therapy can be performed by two ways. That are by stimulating one’s own immune system to fight against the disease by attacking defected cancer cells, and by giving constituents of immune system from outside such as synthetic proteins into the body to fight against the disease. It is performed to treat cancer patients from long, even when the immune system was not well understood by doctors.
Major factors that are driving the growth of the market are increasing occurrence of cancer, Changing life style, Smoking and excessive alcoholic intake, high efficacy of immunotherapy compared to other treatments, less side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer. The major factor restraining the growth of the market is various cancer like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology.
Download free sample report: marketdataforecast.com/market-reports/global-cancer-immunotherap ..
Cancer immunotherapy market is segmented based on Application into Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others. Based on product type, the market is segmented into Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, BCG and others. Based on Mode of administration, the market is segmented into Intravenous, Oral, Topical, and Intravesical. Based on end users, the market is categorized into hospitals, clinics.
Some of the major companies operating in global Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp, Immunomedics
Cancer Immunotherapy Market Segmentation:
• Monoclonal Antibodies
• Checkpoint inhibitors/immune modulators
Mode of Administration
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Jubilee Gardens, Hyderabad,
Team Manager (International Business Development)
# 454 Words